Skip to content

JUFARMA: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

JUFARMA

BE 0882.700.592
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€70,994
2024 · €50,417+€20,576
Equity
€34,467
2024 · -€36,527+€70,994
Cash
€27,259
2024 · €1,657+€25,602
Balance sheet total
€223,918
2024 · €162,439+€61,479

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€28,899

    up €28,899 (+49.2%), from €58,716 to €87,614

  • Cash +€25,602

    up €25,602 (+1545.2%), from €1,657 to €27,259

    mainly Net result for the year (+€70,994) and Trade debts (+€23,581)

  • Receivables within one year +€11,161

    up €11,161 (+18.8%), from €59,443 to €70,603

  • Intangible fixed assets -€7,500

    down €7,500 (-31.3%), from €23,926 to €16,426

Equity and liabilities
  • Profit (loss) carried forward +€65,751

    up €65,751, from -€65,751 to €0

  • Other debts -€30,389

    down €30,389 (-59.1%), from €51,434 to €21,045

  • Trade debts +€23,581

    up €23,581 (+48.0%), from €49,078 to €72,659

  • Debts after one year -€11,311

    down €11,311 (-66.0%), from €17,135 to €5,824

  • Short-term financial debts +€10,000

    up €10,000 (+66.7%), from €15,000 to €25,000

Income statement
  • Gross operating margin +€30,961

    up €30,961 (+23.7%), from €130,812 to €161,772

  • Staff costs +€13,043

    up €13,043 (+36.4%), from €35,787 to €48,830

  • Financial charges -€3,221

    down €3,221 (-43.1%), from €7,481 to €4,260

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €50,417
Gross operating margin +€30,961
Staff costs -€13,043
Depreciation -€831
Other operating charges +€1,084
Financial charges +€3,221
Taxes -€815
Result 2025 €70,994

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€32,288
Investment -€5,846
Financing -€840
Cash 2024 €1,657
Net result for the year +€70,994
Depreciation +€10,528
Stocks and contracts -€28,899
Receivables within one year -€11,161
Deferred charges and accrued income -€500
Trade debts +€23,581
Tax, wage and social debts -€1,925
Other debts -€30,389
Accrued charges and deferred income +€59
Investment in fixed assets (net) -€5,846
Debts after one year -€11,311
Current portion of long-term debt +€471
Short-term financial debts +€10,000
Cash 2025 €27,259
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €162,439 €223,918 +€61,479 +37.8%
Fixed assets 21/28 €41,065 €36,384 -€4,682 -11.4%
Intangible fixed assets 21 €23,926 €16,426 -€7,500 -31.3%
Tangible fixed assets 22/27 €14,139 €16,123 +€1,983 +14.0%
Plant, machinery and equipment 23 €0 - =
Furniture and vehicles 24 €192 €3,762 +€3,569 +1856.1%
Other tangible fixed assets 26 €13,947 €12,361 -€1,586 -11.4%
Financial fixed assets 28 €3,000 €3,835 +€835 +27.8%
Current assets 29/58 €121,373 €187,535 +€66,161 +54.5%
Stocks and contracts in progress 3 €58,716 €87,614 +€28,899 +49.2%
Stocks 30/36 €58,716 €87,614 +€28,899 +49.2%
Amounts receivable within one year 40/41 €59,443 €70,603 +€11,161 +18.8%
Trade receivables 40 €59,443 €70,603 +€11,161 +18.8%
Cash at bank and in hand 54/58 €1,657 €27,259 +€25,602 +1545.2%
Deferred charges and accrued income 490/1 €1,558 €2,058 +€500 +32.1%
Total equity and liabilities 10/49 €162,439 €223,918 +€61,479 +37.8%
Equity 10/15 -€36,527 €34,467 +€70,994
Contributions 10/11 €25,000 €25,000 = 0.0%
Reserves 13 €4,224 €9,467 +€5,243 +124.1%
Tax-exempt reserves 132 €4,224 €4,224 = 0.0%
Distributable reserves 133 - €5,243 +€5,243
Profit (loss) carried forward 14 -€65,751 €0 +€65,751
Provisions and deferred taxes 16 €38,106 €38,106 = 0.0%
Provisions for liabilities and charges 160/5 €38,106 €38,106 = 0.0%
Pensions and similar obligations 160 €38,106 €38,106 = 0.0%
Amounts payable 17/49 €160,860 €151,346 -€9,514 -5.9%
Amounts payable after more than one year 17 €17,135 €5,824 -€11,311 -66.0%
Financial debts 170/4 €17,135 €5,824 -€11,311 -66.0%
Amounts payable within one year 42/48 €143,725 €145,463 +€1,737 +1.2%
Current portion of amounts payable after more than one year 42 €11,763 €12,234 +€471 +4.0%
Financial debts 43 €15,000 €25,000 +€10,000 +66.7%
Credit institutions 430/8 €15,000 €25,000 +€10,000 +66.7%
Trade debts 44 €49,078 €72,659 +€23,581 +48.0%
Suppliers 440/4 €49,078 €72,659 +€23,581 +48.0%
Taxes, remuneration and social security 45 €16,451 €14,526 -€1,925 -11.7%
Taxes 450/3 €11,421 €6,171 -€5,250 -46.0%
Remuneration and social security 454/9 €5,030 €8,355 +€3,325 +66.1%
Other amounts payable 47/48 €51,434 €21,045 -€30,389 -59.1%
Accrued charges and deferred income 492/3 €0 €59 +€59
Non-recurring operating income 76A €7,482 €0 -€7,482 -100.0%
Remuneration, social security and pensions 62 €35,787 €48,830 +€13,043 +36.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,696 €10,528 +€831 +8.6%
Other operating charges 640/8 €1,920 €836 -€1,084 -56.5%
Gross operating margin 9900 €130,812 €161,772 +€30,961 +23.7%
Operating profit (loss) 9901 €83,408 €101,579 +€18,171 +21.8%
Financial charges 65/66B €7,481 €4,260 -€3,221 -43.1%
Recurring financial charges 65 €7,481 €4,260 -€3,221 -43.1%
Profit (loss) for the period before taxes 9903 €75,927 €97,319 +€21,392 +28.2%
Income taxes 67/77 €25,510 €26,325 +€815 +3.2%
Profit (loss) for the period 9904 €50,417 €70,994 +€20,576 +40.8%
Profit (loss) for the period to be appropriated 9905 €50,417 €70,994 +€20,576 +40.8%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.